About: Pierre-Yves Salaun

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pierre-Yves Salaun Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) 研究者 (zh) հետազոտող (hy)
rdfs:label	Pierre-Yves Salaun (en) Pierre-Yves Salaun (es) Pierre-Yves Salaun (nl) Pierre-Yves Salaun (ast)
skos:prefLabel	Pierre-Yves Salaun (en) Pierre-Yves Salaun (es) Pierre-Yves Salaun (nl) Pierre-Yves Salaun (ast)
name	Pierre-Yves Salaun (en) Pierre-Yves Salaun (es) Pierre-Yves Salaun (nl) Pierre-Yves Salaun (ast)
instance of	wds:Q56542262-93DDC53F-DEF8-4D0F-BC53-E9C7E1A6F171
instance of	Homo sapiens
doctoral advisor	wds:Q56542262-01A8DAEA-6F00-49D6-AF6A-46C2B8017ED0
doctoral student	wds:Q56542262-00FA8939-B838-4310-B5E9-3C28E6FBD918 wds:Q56542262-92EC714A-95CF-4845-92A7-86DBC00AB49E
doctoral advisor	Françoise Kraeber-Bodéré
doctoral student	Ronan Abgral Philippe Robin
occupation	wds:Q56542262-44801FCE-E422-412E-8337-1BA3C1EA91F5
employer	wds:Q56542262-778B3F40-2858-4EB0-BF94-CE3147D50EBA wds:Q56542262-B905EE79-B59D-4302-B77A-9AF51855CB81
sex or gender	wds:Q56542262-69c8108e-4a81-c589-54b8-43220b834af3
ISNI	wds:Q56542262-E353ACB3-B45E-4E7C-B594-11823326A65B
VIAF ID	wds:Q56542262-1CB804F5-CEBB-430F-A3B5-9B0036B6CF34
IdRef ID	wds:Q56542262-6E0077F2-9CF5-4AD1-9292-AA7FE1155516
date of birth	wds:Q56542262-B136A74F-7360-4873-94BE-923D8EFC57D4
VIAF ID	http://viaf.org/viaf/208861312
IdRef ID	http://www.idref.fr/072322152/id
occupation	researcher
employer	University Hospital Center of Brest University of Western Brittany
sex or gender	male
ISNI	0000000358664056
VIAF ID	208861312
IdRef ID	072322152
date of birth	1975-01-01 00:00:00Z (xsd:dateTime)
ORCID iD	wds:Q56542262-8E2D3CBA-3FEA-4593-B68E-32B005BBB06C
ORCID iD	https://orcid.org/0000-0002-3899-2135
ORCID iD	0000-0002-3899-2135
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56542262
is author of	Detection of occult wrist fractures by quantitative radioscintigraphy: a prospective study on selected patients. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients Prognostic evaluation of percentage variation of metabolic tumor burden calculated by dual-phase (18) FDG PET-CT imaging in patients with head and neck cancer. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Does18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up? Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy. Diagnostic accuracy of single-photon emission tomography ventilation/perfusion lung scan in the diagnosis of pulmonary embolism. Diagnosis of pulmonary embolism: planar images generated from V/Q SPECT are not a reliable substitute for traditional planar V/Q scan Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma. Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment. Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelines. Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Diagnostic performance of 18 fluorodesoxyglucose positron emission/computed tomography and magnetic resonance imaging in detecting T1-T2 head and neck squamous cell carcinoma. Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma. Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism. Optimized radioiodine therapy for Graves' disease: two MIRD-based models for the computation of patient-specific therapeutic 131I activity. EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program Does PET SUV Harmonization Affect PERCIST Response Classification? Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients. Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data V/Q SPECT interpretation for pulmonary embolism diagnosis: which criteria to use? Safety of ventilation/perfusion single photon emission computed tomography for pulmonary embolism diagnosis. Imaging and identification of brown adipose tissue on CT scan Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus Rituximab: comparison between Deauville 5-point scale and International Harmonization Project criteria. New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France SPECT V/Q for the diagnosis of pulmonary embolism: protocol for a systematic review and meta-analysis of diagnostic accuracy and clinical outcome. Good clinical practice recommendations for the use of PET/CT in oncology Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma Malignancy rate of focal thyroid incidentaloma detected by FDG PET-CT: results of a prospective cohort study ¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma. Noninvasive diagnosis of pulmonary embolism. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score. American consensus recommendations for gastric scintigraphy: curve fitting with only a few points remains an easy and accurate method to obtain reliable and reproducible gastric emptying estimates

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software